ArticleCancer immunology, immunotherapy : CII2021

Improvement of DC-based vaccines using adjuvant TLR4-binding 60S acidic ribosomal protein P2 and immune checkpoint inhibitors.

Gun-Young Jang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.